PCI Biotech Holding ASA (OSL:PCIB)
Norway flag Norway · Delayed Price · Currency is NOK
0.2980
-0.0180 (-5.70%)
Oct 24, 2025, 3:34 PM CET

PCI Biotech Holding ASA Ratios and Metrics

Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
114478775191,041
Upgrade
Market Cap Growth
-82.56%-43.29%2.20%-85.26%-50.14%-63.57%
Upgrade
Enterprise Value
-2143311386832
Upgrade
Last Close Price
0.301.192.102.0513.9127.90
Upgrade
PS Ratio
2.386.5826.1516.1182.77141.34
Upgrade
PB Ratio
0.891.892.001.334.565.50
Upgrade
P/TBV Ratio
0.891.892.001.334.565.50
Upgrade
EV/Sales Ratio
-2.1211.102.2661.49112.91
Upgrade
Debt / Equity Ratio
0.020.010.010.010.020.00
Upgrade
Asset Turnover
0.170.180.060.050.040.03
Upgrade
Quick Ratio
2.943.938.7210.915.809.77
Upgrade
Current Ratio
2.943.988.8010.916.1410.13
Upgrade
Return on Equity (ROE)
-92.47%-52.54%-42.13%-64.37%-58.34%-32.53%
Upgrade
Return on Assets (ROA)
-48.34%-29.82%-25.85%-35.38%-31.16%-20.90%
Upgrade
Return on Capital (ROIC)
-59.86%-35.54%-28.50%-40.58%-35.19%-23.02%
Upgrade
Earnings Yield
-184.02%-37.02%-25.98%-72.00%-17.02%-6.94%
Upgrade
FCF Yield
-147.37%-31.03%-19.14%-77.16%-13.22%-7.81%
Upgrade
Buyback Yield / Dilution
-1.07%----0.11%0.01%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.